Pediatric Nephrology Clinical Trials
Current Pediatric Clinical Trials
AMAG Pharma AMAG-FER-CKD-354
Study title:
A Phase 3, Randomized, OpenLabel, Multicenter Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy, and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects with Chronic Kidney Disease (CKD)
About the study:
This Phase 3, randomized, open-label, multicenter study evaluates the safety (compared to iron sucrose), efficacy, and pharmacokinetics of ferumoxytol (7.0 mg Fe/kg x 2 [max 510 mg/dose]) in pediatric subjects with iron deficiency anemia (IDA) and chronic kidney disease (CKD). Approximately 125 subjects will be randomized to treatment in a 2:1 ratio to either ferumoxytol or iron sucrose.